Dual-mode ClfA-targeting DARPin biologics protect against diverse methicillin-resistant Staphylococcus aureus strains
Chockalingam, K.; Banerjee, B.; Zeng, Y.; Miao, S.; Bryant, J.; Missiakas, D.; Chen, Z.
Show abstract
Staphylococcus aureus uses the adhesin clumping factor A (ClfA) to bind fibrinogen and promote invasive infection through two distinct interfaces: an exposed, low-afinity site on the N3 head domain and a buried, high-afinity "dock, lock, and latch" (DLL) trench that is exposed only under shear. This dual-interface architecture allows limited antibody penetration, as antibodies typically block only the exposed site. Here, we establish a dual-mode inhibition strategy that overcomes this constraint by combining a high-afinity ClfA-binding designed ankyrin repeat protein (DARPin) with a fibrinogen {gamma}-chain peptide capable of occupying the DLL trench. Using cell-free click display and kinetics-guided afinity maturation, we engineer DARPin-{gamma}-peptide fusion biologics that simultaneously block both fibrinogen-binding interfaces. These molecules inhibit ClfA-fibrinogen interactions, prevent methicillin-resistant S. aureus agglutination in human plasma, neutralize major clinical ClfA variants, and confer Fc-independent protection in a lethal murine bacteremia model. This work provides a strategy for targeting antibody-intractable force-activated staphylococcal adhesins.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2 96%
- Engineered Reversible Inhibition of SpyCatcher Reactivity Enables Rapid Generation of Bispecific Antibodies 96%
- A Whole-Cell Screening Platform to Discover Cell Adhesion Molecules that Enable Programmable Bacterial Cell-Cell Adhesion 96%
Similar papers in this journal
Similar papers in this journal
- Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses 95%
- Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike 95%
- Mapping essential somatic hypermutations in a CD4-binding site bNAb informs HIV-1 vaccine design 95%
Similar papers in this journal
- Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralising SARS-CoV-2 nanobodies 96%
- Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response 95%
- Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.